Bristol-Myers executive charged with insider trading
A Bristol-Myers Squibb Co executive has been criminally charged with insider trading, accused of buying options in three companies that the drugmaker was looking to buy.
A former Goldman Sachs trader and his father have been charged with insider trading by US regulator the Securities and Exchange Commission.